4.92
price down icon3.72%   -0.19
after-market アフターアワーズ: 4.95 0.03 +0.61%
loading
前日終値:
$5.11
開ける:
$5.15
24時間の取引高:
4.11M
Relative Volume:
0.70
時価総額:
$1.47B
収益:
$38.03M
当期純損益:
$-146.40M
株価収益率:
-9.4615
EPS:
-0.52
ネットキャッシュフロー:
$-121.38M
1週間 パフォーマンス:
-4.47%
1か月 パフォーマンス:
+36.29%
6か月 パフォーマンス:
+49.09%
1年 パフォーマンス:
+50.92%
1日の値動き範囲:
Value
$4.8912
$5.1868
1週間の範囲:
Value
$4.67
$5.36
52週間の値動き範囲:
Value
$1.8906
$5.82

Abcellera Biologics Inc Stock (ABCL) Company Profile

Name
名前
Abcellera Biologics Inc
Name
セクター
Healthcare (1164)
Name
電話
(604) 559-9005
Name
住所
150 W 4TH AVENUE, VANCOUVER
Name
職員
596
Name
Twitter
Name
次回の収益日
2024-11-18
Name
最新のSEC提出書
Name
ABCL's Discussions on Twitter

ABCL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ABCL
Abcellera Biologics Inc
4.92 1.53B 38.03M -146.40M -121.38M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-07 再開されました Leerink Partners Outperform
2024-08-20 ダウングレード The Benchmark Company Buy → Hold
2024-02-22 アップグレード The Benchmark Company Hold → Buy
2023-12-05 開始されました KeyBanc Capital Markets Overweight
2023-11-06 ダウングレード The Benchmark Company Buy → Hold
2023-10-13 再開されました Piper Sandler Overweight
2023-02-28 開始されました Cowen Outperform
2022-12-15 開始されました Goldman Buy
2022-11-16 開始されました Truist Buy
2021-12-21 開始されました The Benchmark Company Buy
2021-11-19 開始されました Piper Sandler Overweight
2021-01-05 開始されました BMO Capital Markets Outperform
2021-01-05 開始されました Berenberg Buy
2021-01-05 開始されました Credit Suisse Outperform
2021-01-05 開始されました SVB Leerink Outperform
2021-01-05 開始されました Stifel Buy
すべてを表示

Abcellera Biologics Inc (ABCL) 最新ニュース

pulisher
10:55 AM

Why AbCellera Biologics Inc. stock is on top investor watchlistsEntry Plan for Oversold Reversal Stocks Released - beatles.ru

10:55 AM
pulisher
05:40 AM

How strong is AbCellera Biologics Inc. company’s balance sheetChart Pattern Trend Scanner With Low Risk - jammulinksnews.com

05:40 AM
pulisher
04:38 AM

Does AbCellera Biologics Inc. stock perform well during market downturnsMaximize gains with proven stock analysis - jammulinksnews.com

04:38 AM
pulisher
12:44 PM

What is the dividend policy of AbCellera Biologics Inc. stockStay informed with daily expert analysis - jammulinksnews.com

12:44 PM
pulisher
Jul 27, 2025

What are analysts’ price targets for AbCellera Biologics Inc. in the next 12 monthsLow Risk Alerts With Proven Results - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is AbCellera Biologics Inc. stock expected to show significant growthSuperior return velocity - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell AbCellera Biologics Inc. stock in 2025Get alerts on high-potential stock breakouts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does AbCellera Biologics Inc. compare to its industry peersHarness the power of proven investment plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is AbCellera Biologics Inc. stock overvalued or undervaluedGet exclusive market analysis for investors - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does AbCellera Biologics Inc. generate profit in a changing economyStay ahead with daily expert stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

AbCellera Biologics Inc. (ABCL): A Bull Case Theory - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

Why AbCellera Biologics Inc. stock attracts strong analyst attentionBreakout Momentum Alerts - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

AbCellera’s AI Antibody Platform Excites Investors, Despite Big Risks - Finimize

Jul 26, 2025
pulisher
Jul 25, 2025

Is AbCellera Biologics Inc. a good long term investmentConsistent double returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

AbCellera Biologics Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is AbCellera Biologics Inc. stock a good hedge against inflationSkyrocketing profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about AbCellera Biologics Inc. stockRapid wealth creation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives AbCellera Biologics Inc. stock priceExponential return rates - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

AbCellera: Just Another Biotech Stock (NASDAQ:ABCL) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Leerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following Pivot - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? - MSN

Jul 23, 2025
pulisher
Jul 21, 2025

ABCL.O Surges 15.5% Intraday: A Deep Dive Into the Drivers Behind the Sharp Move - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ABCL Stock Surge: Opportunity or Caution? - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

AbCellera Biologics Stock (ABCL) Opinions on Recent Price Surge - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

AbCellera Biologics (ABCL) Surges 18.75% Intraday: What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025

Abcellera Biologics Inc (ABCL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
大文字化:     |  ボリューム (24 時間):